Free Pick from Jeff Brown: “Buy S.C.G .”
Jeff Brown picked Tesla in 2018 before it jumped 1,390%. He picked Nvidia before it jumped 3,545%. And he picked Bitcoin before it skyrocketed 22,750%.

And now he’s saying S.C.G. will be the next big tech play. He’s not the only one. Apple’s CEO even called it “the next big thing.”
Click here and get the name and ticker symbol!
Thomas E. Timbie, insider at Treace Medical Concepts
Thomas E. Timbie Insider Alerts

Get notified the next time Thomas E. Timbie buys or sells Treace Medical Concepts stock. Enter your email address below to get our daily insider buying and selling report.

Thomas E. Timbie Insider Information

Thomas E. Timbie has served as a member of our board of directors since June 2014 and served as our Chief Financial Officer from July 2014 to October 2015. Mr. Timbie is the President of Timbie & Company, LLC, a financial and management consulting firm he founded in 2000. Mr. Timbie has over 30 years of financial experience primarily in the medical device market. During 2005, as the interim Chief Financial Officer of ev3 Inc., acquired by Covidien in 2010 and now part of Medtronic plc. (NYSE: MDT), Mr. Timbie helped lead ev3 through their initial public offering. He was also the Chief Financial Officer of Xomed Surgical Products, Inc., including during its initial public offering in 1996, and continuing in that role until Xomed was acquired by Medtronic plc (NYSE: MDT) in 1999. Prior to Xomed, Mr. Timbie was the Chief Financial Officer of TreBay Medical Corp., a private orthopaedic and microsurgical device company, and the Director of Accounting at Concept Inc., a leader in the arthroscopy device market, now known as Conmed Linvatec (NYSE: CNMD). Timbie has also previously served as a member of the board of directors of Wright Medical Group, Inc., acquired by Stryker Corporation (NYSE: SYK) in November 2020; ev3 Inc., until its acquisition by Covidien (part of Medtronic plc. (NYSE: MDT)); and American Medical Systems, Inc., now part of Endo Pharmaceuticals (NASDAQ: ENDP). Mr. Timbie holds a B.S. in Accounting from University of Florida, an M.B.A. from Stetson University and is a certified public accountant (current status inactive). Mr. Timbie has also served as a board member and audit committee chairman of several public and private medical device companies including Wright Medical, Inc. acquired by Stryker Corporation (NYSE: SYK) in November 2020; ev3 Inc., acquired by Covidien in 2010 and now part of Medtronic plc. (NYSE: MDT); Acclarent, Inc., acquired by Johnson & Johnson (NYSE: JNJ) in 2010; and American Medical Systems, Inc. acquired by Endo Pharmaceuticals (NASDAQ: ENDP) in 2011. Mr. Timbie is also a former board member and audit committee chairman of two health care services companies, LaVie Care Centers and RegionalCare Hospital Partners.

How old is Thomas E. Timbie?

Mr. Timbie is currently 63 years old. There are 7 older executives and no younger executives at Treace Medical Concepts. Learn More.

How do I contact Thomas E. Timbie?

The corporate mailing address for Mr. Timbie and other Treace Medical Concepts executives is 203 FORT WADE RD. SUITE 150, PONTE VEDRA FL, 32081. Treace Medical Concepts can also be reached via phone at 904-373-5940 and via email at [email protected]

Has Thomas E. Timbie been buying or selling shares of Treace Medical Concepts?

Thomas E. Timbie has not been actively trading shares of Treace Medical Concepts during the last quarter. Most recently, Thomas E. Timbie sold 11,171 shares of the business's stock in a transaction on Wednesday, October 20th. The shares were sold at an average price of $25.18, for a transaction totalling $281,285.78.

Who are Treace Medical Concepts' active insiders?

Treace Medical Concepts' insider roster includes Sean Scanlan (SVP), Thomas Timbie (Director), James Treace (Director), and John Treace (CEO).

Are insiders buying or selling shares of Treace Medical Concepts?

During the last twelve months, Treace Medical Concepts insiders bought shares 1 times. They purchased a total of 10,000 shares worth more than $170,000.00. During the last twelve months, insiders at the sold shares 25 times. They sold a total of 6,590,778 shares worth more than $113,119,004.98. The most recent insider tranaction occured on January, 18th when Director James T Treace sold 42,937 shares worth more than $835,554.02.

Information on this page was last updated on 1/18/2022.

Thomas E. Timbie Insider Trading History at Treace Medical Concepts

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/20/2021Sell11,171$25.18$281,285.78View SEC Filing Icon  
See Full Table

Thomas E. Timbie Buying and Selling Activity at Treace Medical Concepts

This chart shows Thomas E Timbie's buying and selling at Treace Medical Concepts by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Treace Medical Concepts Company Overview

Treace Medical Concepts logo
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of device and/or biologic solutions for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was incorporated in 2014 and is headquartered in Ponte Vedra Beach, Florida.
Read More

Today's Range

Now: $19.57
Low: $19.09
High: $20.44

50 Day Range

MA: $18.33
Low: $15.48
High: $21.77

2 Week Range

Now: $19.57
Low: $15.00
High: $37.17

Volume

239,125 shs

Average Volume

301,571 shs

Market Capitalization

$1.04 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
Free Pick from Jeff Brown: “Buy S.C.G .”
Jeff Brown picked Tesla in 2018 before it jumped 1,390%. He picked Nvidia before it jumped 3,545%. And he picked Bitcoin before it skyrocketed 22,750%.

And now he’s saying S.C.G. will be the next big tech play. He’s not the only one. Apple’s CEO even called it “the next big thing.”
Click here and get the name and ticker symbol!